Gardiner Healthcare Acquisitions Corp. Common Stock
GDNR
GDNR was delisted on the 15th of December, 2023.
0 hedge funds and large institutions have $0 invested in Gardiner Healthcare Acquisitions Corp. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.
100% less funds holding
Funds holding: 14 → 0 (-14)
100% less capital invested
Capital invested by funds: $16.2M → $0 (-$16.2M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 14
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$3.47M |
| 2 |
OCAM
Owl Creek Asset Management
New York
|
-$2.31M |
| 3 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$2.17M |
| 4 |
MSU
Mizuho Securities USA
New York
|
-$1.67M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$1.63M |
GDNR Hedge Fund Activity: Q4 2023 in Review
0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Gardiner Healthcare Acquisitions Corp. Common Stock (GDNR) for Q4 2023, worth a combined $0 — down 100% from $16.2M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of GDNR and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Meteora Capital, exiting entirely with an estimated $3.47M sold.
- 0 institutional investors held Gardiner Healthcare Acquisitions Corp. Common Stock (GDNR) as of Q4 2023, down from 14 in Q3 2023.
- Funds reported $0 of Gardiner Healthcare Acquisitions Corp. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Gardiner Healthcare Acquisitions Corp. Common Stock positions in Q4 2023 and 14 closed out, a net change of -14 holders.
- The largest Gardiner Healthcare Acquisitions Corp. Common Stock seller in Q4 2023 was Meteora Capital, an estimated $3.47M sold.
Based on aggregated 13F filings for Q4 2023.